Catalyst Advisors, a global executive search firm, has produced an analysis of leadership dynamics in today’s biopharma industry. The paper outlines how continued industry disruption has affected the types of leaders companies need to guide them through a period of unprecedented change. The paper provides an instant snapshot of the main change drivers, the resulting operational implications for the biopharma industry and the strategic impact on companies.
In this new world, biopharma firms are no longer limited to playing pharma’s precocious younger sibling but instead can aspire to stand on roughly equal footing in terms of valuation and market presence.
The paper discusses
- How new economic realities are eroding traditional boundaries in drug discovery
- The challenge of finding leaders in the “transformational triangle” that combines entrepreneurialism, a stellar track record and critical functional attributes
- The specific qualities in top demand for various leadership roles
- How the rise of social networking sites has placed a greater emphasis on assessment in the search process.